Advertisement
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action

Robert J. Slack, Victoria J. Barrett, Valerie S. Morrison, Richard G. Sturton, Amanda J. Emmons, Alison J. Ford and Richard G. Knowles
Journal of Pharmacology and Experimental Therapeutics January 2013, 344 (1) 218-230; DOI: https://doi.org/10.1124/jpet.112.198481
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

In Vitro Pharmacology of Vilanterol

Robert J. Slack, Victoria J. Barrett, Valerie S. Morrison, Richard G. Sturton, Amanda J. Emmons, Alison J. Ford and Richard G. Knowles
Journal of Pharmacology and Experimental Therapeutics January 1, 2013, 344 (1) 218-230; DOI: https://doi.org/10.1124/jpet.112.198481
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement